Larry founded Santegic after two decades working across digital health, public health technology, and enterprise software, including leading large-scale deployments for governments and healthcare providers during the Covid-19 pandemic. That experience, seeing first-hand what happens when great technology meets unprepared systems, fragmented regulation, and mounting cyber risk is what gave rise to Santegic.

His conviction is simple: healthcare deserves advisors who genuinely understand it. Not generalists applying a generic framework to a sector they've never worked inside.

Today Larry leads a team of specialists spanning compliance, regulatory strategy, digital transformation, and cybersecurity bringing together the two disciplines that healthcare organisations increasingly can't separate. He is a regular voice on the convergence of healthcare regulation, cyber resilience, and patient safety, and leads the South Chapter of the Connected Health & Wellbeing Cluster.

Previously Co-founder of Crystal Valley Tech and former Chair of Linux Foundation for Public Health.

Clare Harney brings 25 years of experience working inside health and social care, not advising from the outside, but embedded in the organisations shaping how Ireland's health system thinks about digital transformation, governance, and innovation. That insider knowledge is what she brings to every client engagement at Santegic.

As Principal Advisor and leader of Santegic's Advisory division, Clare works with health systems and health tech companies on the challenges that sit between a good idea and real-world deployment, regulatory navigation, compliance strategy, health data governance, and the structured thinking that turns innovation into something fundable, scalable, and safe.

Her credibility is built across three interconnected worlds. As a practitioner, she has held senior roles across the Department of Health, HIQA, and the HSE including leading work on the forthcoming HSE Framework for Innovation and the HSE Data Strategy. As a recognised leader, she was named CIO & IT Leader of the Year 2023 by the Irish Computer Society, of which she is also a Fellow and Honorary Secretary. And as an educator, she leads the Postgraduate Diploma in Digital Health Transformation at RCSI, supervises MSc candidates, and mentors the next generation of digital health leaders through the DigiBio Fellowship and Connected Health Cluster.

Clare holds an MSc in Health Informatics, a postgraduate qualification in MDR/IVDR compliance, and a Bachelor ofInformation Systems.

Anita Finnegan has spent 15 years advising boards and senior leadership teams on cybersecurity risk in some of the most complex, high-stakes environments imaginable. Her conviction is straightforward: in healthcare, cybersecurity isn't just a technical problem. It's a patient safety issue, and it has to be treated as one.

As Principal and leader of Santegic Cyber, Anita works with healthcare providers, health technology companies and MedTech organisations to do something most cybersecurity advisors can't help them not just understand their security posture, but evidence it in a clear, structured and defensible way. Because in healthcare procurement, regulation and governance, being able to prove your cybersecurity matters as much as having it.

Her credentials are internationally recognised in a way that sets her apart. She holds a PhD in Cybersecurity Risk Management, is the author of two published international cybersecurity standards shaping both EU and US regulatory environments, and serves as an Independent Expert Evaluator for the European Commission in cybersecurity and third-party risk management. Prior to joining Santegic, she founded and led a global cybersecurity company focused on connected device risk management directly shaping the medical device cybersecurity frameworks that her clients now need to navigate.

That depth of experience means Anita doesn't just respond to the regulatory landscape. She helps shape it and brings that perspective directly to every client engagement.

She is a frequent keynote speaker at international cybersecurity, healthcare and regulatory forums, and a founding participant in the CyberHealth Special Interest Group, established by the Connected Health & Wellbeing Cluster and Cyber Ireland.

Mike Kelliher has led organisations through every stage of the lifecycle. From startup and early growth through to restructuring and transformation, Mike brings that full-spectrum experience to every client engagement at Santegic. His lens is consistently practical: does it deliver real value, and are we structured to deliver it well?

As Senior Consultant, Mike works at the intersection of product development, operational delivery, and technology partnerships, the part of the journey where strategy has to become something that actually works in the real world. He has a particular focus on helping health technology companies build the right foundations early: structuring requirements, roadmaps, and operational frameworks that can survive procurement scrutiny, regulatory review, and the demands of scaling in a complex sector.

His coaching background, he is a qualified executive coach, shapes how he works with teams as much as organisations. He is currently Mentor in Residence at the DigiBio Healthtech Innovation Programme, supporting the next generation of Irish healthtech founders with product development, operational structure, and leadership.

Mike holds a postgraduate business qualification from Michael Smurfit UCD Business School and brings cross-sector experience in engineering, operations, and product delivery that complements the deep healthcare specialism of the wider Santegic team.

Tom Hennessy brings something no other member of the Santegic team does. A deep, active understanding of the US healthcare market and what it takes to operate successfully on both sides of the Atlantic.

As Senior Advisor, Tom works with European healthtech companies navigating the complexity of US market entry, and with US healthcare organisations and vendors looking to establish a credible presence in Ireland, the UK, and Europe. In a sector where regulatory environments, reimbursement models, and procurement cultures differ enormously between markets, that dual-direction fluency is rarely found in a single advisor.

His grounding spans entrepreneurship, senior executive leadership, and academia. He is an Adjunct Professor with extensive experience building and scaling businesses across healthcare and ICT. That combination of theoretical rigour and commercial reality shapes how he works with clients: identifying not just what the opportunity is, but what it actually takes to capture it.

Tom is the author of "Headlines to Handrails", a weekly newsletter published through Santegic that takes the latest US healthcare policy developments and translates them into practical guidance for healthtech leaders. From CMS reimbursement shifts and FDA regulatory updates to the implications of AI entering clinical decision-making, his writing consistently turns complex policy signals into clear, actionable intelligence for companies making market decisions.

He is educated at the University of Maryland Baltimore County and brings a network and market knowledge that gives Santegic, and its clients, genuine reach into the US healthcare ecosystem.

Paul Breen brings a perspective that is rare in the healthtech advisory world. That of a founder who has taken a novel pharmaceutical product from concept through European regulatory approval to global commercial launch.

As a Strategic Advisor and Director at Santegic, Paul helps shape the firm's direction and growth, bringing the hard-won insight of someone who has navigated the full journey from idea to market in one of the most regulated environments in the world. His experience as Founder and Director of BrePco Biopharma, Marketing Authorisation Holder for Neoatricon®, the only EU-licensed dopamine formulation for paediatric patients, gives him a firsthand understanding of what it takes to move through EMA approval, international commercialisation, and global partnership at the highest level.

That experience informs everything he contributes to Santegic. Where others advise on compliance and market access in theory, Paul has lived it, managing regulatory strategy, clinical evidence requirements, and commercial partnerships with global pharma organisations across the EU, UK, and beyond.

His lens is that of a senior global life sciences leader, and it brings a dimension to Santegic's offering that bridges healthtech innovation and the broader pharmaceutical and biopharma world, a connection that matters increasingly as the boundaries between digital health, MedTech, and pharma continue to converge.